Entereg helps restore bowel function in hospitalized patients
Entereg is a new drug to help hospitalized patients who have undergone abdominal surgery restore their bowel functions.
Hospital pharmacists will soon have a new drug they have to get trained on. It’s Entereg (alvimopan), designed to restore bowel function in adults who have undergone abdominal surgery and are on pain medication. Offered by Adolor Corp. and GlaxoSmithKline, the peripherally acting mu-opioid receptor has strict requirements that users must meet. Only hospitals that are certified can dispense the product, which should only be used for inpatients for the short term.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
